Venrock Partners Management, LLC, 10% Owner at Bellerophon Therapeutics, Inc. (BLPH), bought 160,000 shares at $0.90 ($139K) on 2018-09-07, disclosed to the SEC on 2018-09-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.85 | 50,000 | $43K | 30.7% |
| 2 | $0.84 | 50,000 | $42K | 30.3% |
| 3 | $0.90 | 60,000 | $54K | 39.0% |
| Total | $0.87 avg | 160,000 | $139K | 100% |